Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Videos
Management of Adverse Events Associated with PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
FEATURING:
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
October 11, 2020
Interview with the Innovators
Watch Video
Combination Therapy as Maintenance in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
October 6, 2020
Interview with the Innovators
Watch Video
Clinical Data on First-Line Maintenance Therapy in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
September 15, 2020
Interview with the Innovators
Watch Video
Choosing Among PARP Inhibitors as Maintenance Therapy in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
September 8, 2020
Interview with the Innovators
Watch Video
Choosing Maintenance Therapy in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
August 18, 2020
Interview with the Innovators
Watch Video
A Review of Clinical Trials Suggesting the Use of PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
August 11, 2020
Interview with the Innovators
Watch Video
Changes in HRD “Fingerprints” in Patients with Ovarian Cancer and Their Impact on Clinical Outcomes
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
July 28, 2020
Interview with the Innovators
Watch Video
The Impact of Germline or Somatic HRD Testing on Treatment Decisions in Ovarian Cancer
FEATURING:
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
July 14, 2020
Interview with the Innovators
Watch Video
The Role of Genetic Testing in Patients with Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
June 24, 2020
Interview with the Innovators
Watch Video
Page 8 of 17
5
6
7
8
9
10
11